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Abstract
Background: The rearrangements of the 22q11.2 chromosomal region, most frequently deletions and duplications,
have been known to be responsible for multiple congenital anomaly disorders. These rearrangements are
implicated in syndromes that have some phenotypic resemblances. While the 22q11.2 deletion, also known as
DiGeorge/Velocardiofacial syndrome, has common features that include cardiac abnormalities, thymic hypoplasia,
characteristic face, hypocalcemia, cognitive delay, palatal defects, velopharyngeal insufficiency, and other
malformations, the microduplication syndrome is largely undetected. This is mainly because phenotypic appearance
is variable, milder, less characteristic and unpredictable. In this paper, we report the clinical evaluation and follow-
up of two patients affected by 22q11.2 rearrangements, emphasizing new phenotypic features associated with
duplication and triplication of this genomic region.
Case Presentation: Patient 1 is a 24 year-old female with 22q11.2 duplication who has a heart defect (ostium
secundum atrial septal defect) and supernumerary teeth (hyperdontia), a feature previously not reported in patients
with 22q11.2 microduplication syndrome. Her monozygotic twin sister, who died at the age of one month, had a
different heart defect (truncus arteriousus). Patient 2 is a 20 year-old female with a 22q11.2 triplication who had a
father with 22q11.2 duplication. In comparison to the first case reported in the literature, she has an aggravated
phenotype characterized by heart defects (restrictive VSD and membranous subaortic stenosis), and presented
other facial dysmorphisms and urogenital malformations (ovarian cyst). Additionally, she has a hemangioma planum
on the right side of her face, a feature of Sturge-Weber syndrome.
Conclusions: In this report, we described hyperdontia as a new feature of 22q11.2 microdeletion syndrome.
Moreover, this syndrome was diagnosed in a patient who had a deceased monozygotic twin affected with a
different heart defect, which corresponds to a phenotypic discordance never reported in the literature. Case 2 is the
second clinical report of 22q11.2 triplication and presents an aggravated phenotype in contrast to the patient
previously reported.
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Background
The rearrangements of the 22q11.2 chromosomal re-
gion, specifically deletions and duplications, have been
known to be responsible for multiple congenital anom-
aly disorders [1, 2]. The 22q11.2 deletion causes
22q11.2 deletion syndrome, also known as DiGeorge/
Velocardiofacial syndrome (DGS/VCFS), which has a
prevalence estimated between 1:2000-1:17000 live
births [3]. About 90 % of these deletions are de novo,
while 10 % are inherited from an affected parent [4].
DGS/VCFS is characterized by a wide spectrum of clinical
features that include: cardiac abnormalities, particularly
conotruncal malformation; thymic and parathyroid hypo-
plasia; facial dysmorphisms; cognitive delay; palatal defects;
velopharyngeal insufficiency; behavioral problems; hearing
loss; limb deformity; and feeding difficulty, amongst others.
The penetrance of each feature is variable, i.e., no sin-
gle phenotype happens in all patients and none is
obligatory [4–7].
Recently, 22q11.2 microduplication syndrome has
been considered a different clinical entity than 22q11.2
deletion syndrome [2]. Recent data suggest that the
frequency of duplications is approximately half of the
deletions, mainly because duplications are largely un-
detected − phenotypic appearance is variable, milder,
less characteristic, and unpredictable. Inherent meth-
odological issues also contribute to difficulties in the
diagnosis of this condition [2, 8–10]. Based on the
current literature, the phenotypes of 22q11.2 deletion
and 22q11.2 microduplication syndromes sometimes
overlap, but this is correlated to ascertainment bias
and might represent a slight part of the wide range
spectrum of these syndromes [1, 10, 11].
The triplication of the 22q11.2 region was only re-
ported in one study, in which the patient had a very mild
phenotype, specifically speech delay, learning difficulties,
and dysmorphic features (broad nasal bridge, hand/foot
abnormality, epicanthal folds, eversion of the lateral eye
lids, and bulbous nasal tip) [10].
In this paper, we report the clinical evaluation and
follow-up of two patients affected by 22q11.2
rearrangements that we have recently characterized
using molecular techniques [12]. Furthermore, we de-
scribe hyperdontia as a new feature of 22q11.2 micro-
deletion syndrome and report the clinical features of a
patient who carries a 22q11.2 triplication, which is ex-




The index case (corresponding to patient C in Pires
et al. [12]) is a 24 year-old female who is the third child
of consanguineous parents (a 26 year-old mother and a
30 year-old father). The patient was born at term
(39 weeks of gestation), by vaginal delivery, with a birth
weight of 2450 g (5th centile) and length of 47 cm (10th
centile). Apgar scores were 1 at the first minute and 10
at the fifth minute. The patient had a monozygotic
twin sister affected by truncus arteriosus, who under-
went heart surgery, but died at the age of 1 month. The
family history revealed another three deceased siblings:
the first was a girl who died at the age of 9 months with
a possible heart disease; the second was a stillborn boy;
the third was a girl who died at the age of 13 months
with a diagnosis of pulmonary atresia and ventricular
septal defect (VSD). The mother has a history of
hyperthyroidism and hypertension; the father has
rheumatoid arthritis; both have learning difficulties.
Maternal grandparents and the paternal grandfather
died of unspecified heart disease. At the age of 9 years,
the patient was suspected of having a heart condition
due to the presence of a heart murmur and failure to
thrive. An echocardiogram showed an ostium secun-
dum atrial septal defect (ASD), which required heart
surgery. Facial dysmorphisms were perceived, suggest-
ing DGS/VCFS (Fig. 1a and b). She had recurrent
upper respiratory tract infections that required adenoi-
dectomy at the age of 15. She also underwent otorhino-
laryngology surgery, due to an infected auricular
fistula, and received an otoplasty to correct a pinna de-
formity (Table 1).
Fig. 1 Facial appearance of patient 1 with 22q11.2 microduplication syndrome. a Front view. b Side view. c Hyperdontia
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Table 1 Clinical characterization of two patients with 22q11.2 alterations and comparison with previously reported cases
Features Case 1 Other casesa Case 2 Yobb et al., 2005 [10]
Patient Father Patient Mother
22q11.2 region Dup Dup Trip Dup Trip Dup
Age at last evaluation (years) 24 20 63 8
Gender F F M F F
Heart defect + + + −
Velopharyngeal insufficiency − + + −
Palatal defect + + − −
Hearing impairment − + + +c
Failure to thrive − + − −
Roncopathy/sleep apnea − + + −
Urogenital abnormalities − + + −
Cognitive deficits + + +b + −
Psychiatric disorders + + +
Behavioral problems − + +
Seizures − + − −
Headache + +b
Hand/foot abnormality − + − + +
Dysmorphic features
− Head
Microcephaly − + − −
Long narrow face + + +
Proeminent forehead + + −
− Eyes
Hypertelorism + + +
Epicanthal folds + + + +
Upslanting palpebral fissures + + −
Downslanting palpebral fissures − + +
Superior placement of eyebrows + + −
Strabismus − + +b
Myopia + + +b
− Nose
Broad nasal bridge + + −
Proeminent nose + + +
Long philtrum + +
Smooth philtrum + + +
− Ears
Dysplastic ears + + −
Preauricular fistula + + −
− Mouth
Micrognathia + + − −
Retrognathia + + +
Supernumerary teeth (hyperdontia) + −
Dental cavities + + +
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Currently, the patient has mild developmental delay and
learning difficulties, hyperdontia (supernumerary teeth;
Fig. 1c), and dental cavities. Nonetheless, she is living an in-
dependent life and is currently married. In order to investi-
gate the presence of 22q11.2 deletion, which is associated
with DGS/VCFS, and other genomic alterations, we per-
formed multiplex ligation-dependent probe amplification
(MLPA) and array comparative genomic hybridization
(array-CGH), respectively [12]. Both techniques detected a
de novo duplication (1:2, one normal chromosome and a
22q11.2 duplication in the other) of 2.5 Mb (nucleotide po-
sitions 18,894,835 to 21,464,119) [12], supporting the diag-
nosis of 22q11.2 microduplication syndrome.
Case 2
This patient, a 20 year-old female who corresponds to
patient B in Pires et al. [12], is the eighth child of a
42 year-old mother and a 43 year-old father; the latter
presents mild intellectual disability and learning diffi-
culties. She was born at 38 weeks of gestation by spon-
taneous vaginal delivery. The patient has seven normal
siblings. At birth, she weighed 2950 g (5th centile), her
height was 46 cm (5th centile), and head circumference
was 34 cm (25th centile). Apgar scores were 9 at the
first minute and 10 at the fifth minute. She had a
hemangioma planum on the right side of her face, low
set ears, and convergent strabismus on the right eye
(Table 1). In infancy, the transfontanelar ultrasound
and the computed tomography (CT) scan of the head
were both normal. In the first years of her life, she was
diagnosed with failure to thrive, developmental delay,
hearing impairment, multiple upper respiratory infec-
tions, and restrictive VSD and membranous subaortic
stenosis, which required surgery. At 13 years of age, a
large ovarian cyst was diagnosed.
At 15 years of age, she was diagnosed with Sturge-
Weber syndrome. A CT scan showed ocular asym-
metry with greater dimensions of the left eye, hyper-
caption of contrast product in the external posterior
wall of the right eyeball, and an almost absent mastoid
pneumatization.
Currently, she has moderate cognitive and language
impairment, and is dependent for most daily activities.
Due to the heart defects, we performed the analysis of
the of 22q11.2 region by MLPA, fluorescent in situ
hybridization (FISH), and array-CGH [12]. MLPA identi-
fied four copies of this region, whereas FISH confirmed
a tetrasomy (1:3, one normal chromosome and a
22q11.2 triplication in the other) that was most likely
inherited from a paternal duplication (1:2) with an extra
copy [12]. Moreover, the array-CGH showed a triplica-
tion of 3 Mb (nucleotide positions 18,661,724 to
21,917,251) [12].
Conclusions
The two cases described illustrate the phenotypic vari-
ability associated with rearrangements of the 22q11.2
chromosomal region. We establish the similarities and
differences between the two patients with the 22q11.2
variants, revealing hyperdontia as a new characteristic of
the 22q11.2 microduplication syndrome and new fea-
tures concerning triplication of the 22q11.2 region.
Only a few patients with 22q11.2 microduplication
syndrome and concomitant heart defects have been re-
ported [11, 13]. Patient 1 had an ASD that required
surgery. At birth, the diagnosis of DGS/VCFS was sug-
gested due to facial dysmorphisms, failure to thrive,
and a strong family history of heart diseases and sud-
den death syndrome. At that time it was not possible
to perform specific techniques to diagnose 22q11.2 du-
plication. Even though having mild developmental
delay, she lives an independent life. It is essential to
emphasize two clinical aspects. First, the existence of
an anomaly like hyperdontia, which was never reported
as being associated to the 22q11.2 microduplication
syndrome (Table 1). Second, the fact that her monozy-
gotic twin sister, who died at the age of one month,
had a different heart defect, which demonstrate that
other factors − post-zygotic genetic, epigenetic, environ-
mental and stochastic − could affect human heart develop-
ment. These factors may contribute to the discordance of
congenital heart disease (CHD) in monozygotic twins [14].
Table 1 Clinical characterization of two patients with 22q11.2 alterations and comparison with previously reported cases (Continued)
Additional features
− Recurrent infections + + +
− Skeletal
Hiperlaxity − + −
Other − + −
− Dermatologic abnormalities − +b
− Allergies + +
aAccording to [2, 10, 23, 24]
bSturge-Weber syndrome’s symptoms that are likely unrelated to the 22q11.2 triplication
cHearing impairment was probably secondary to otitis media
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Despite this discordance that has been described in mono-
zygotic twins with DGS/VCFS [15, 16], it was never associ-
ated with 22q11.2 microduplication syndrome.
Patient 2, who has a father with 22q11.2 duplication
and a normal mother, presents a triplication of the
22q11.2 region and, to our knowledge, this is the sec-
ond case described in literature [10, 12]. In comparison
to the first reported case, who presented speech delay,
learning difficulties, and dysmorphic features, patient 2
has an aggravated phenotype characterized by heart
defects (restrictive VSD and membranous subaortic
stenosis), and presented other facial dysmorphisms
and urogenital malformations (ovarian cyst; Table 1).
The patient also has a hemangioma planum on the
right side of her face. This latter sign is consistent with
one of the diagnostic criteria of Sturge-Weber syn-
drome. As we know, this syndrome is a sporadic con-
genital neurocutaneous disorder, caused by a somatic
activating mutation (c.548G > A, p.Arg183Gln) in
GNAQ gene [17]. Clinically, it is characterized by the
presence of nevus flammeus (port-wine stain), involv-
ing the area of the first sensory branch of the trigemi-
nal nerve. The second and third trigeminal branches
might be involved, by cerebral venous malformations (ip-
silateral leptomeningeal angiomatosis) and by glaucoma
with ocular capillary venous vascular malformations
[18–20]. Sturge-Weber syndrome has been associated
with epilepsy, behavioral disorders, cognitive impair-
ment, headaches, spastic hemiparesis, and visual fields
defects [18–22]. In fact, patient 2 presents similar fea-
tures (Table 1) and possibly has the somatic mutation
c.548G > A (p.Arg183Gln) in the GNAQ gene.
In summary, here we report hyperdontia as a new fea-
ture of 22q11.2 microdeletion syndrome. This syndrome
was diagnosed in a patient who had a deceased monozy-
gotic twin affected with a different heart defect, which
corresponds to a phenotypic discordance never reported
in the literature. Moreover, we reinforce that physicians
should pay attention to the resemblances between
22q11.2 microduplication and deletion syndromes, in
order to avoid misdiagnosis. Therefore, these two syn-
dromes should be considered in the presence of a pa-
tient with a dysmorphic face associated with CHD,
thymic hypoplasia, developmental delay, and other mal-
formations. Patients with triplication of 22q11.2 region
are extremely rare and case 2 presented an aggravated
phenotype in contrast to the previously reported, which
has a milder phenotype. Both triplication cases fit within
the 22q11.2 duplication spectrum. Some factors may
contribute to their phenotypic variability, such as differ-
ences in genetic background, different genetic dosages,
abnormalities in the parent of origin or imprinted
chromosomal material (e.g., uniparental disomy). Finally,
we suggest that duplications and triplications could be
underdiagnosed, particularly if evaluated by FISH in
metaphase spreads. Molecular tests, like MLPA or array-
CGH, could be more adequate.
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